Enumeration of haemagglutinin-specific CD8 + T cells after influenza vaccination using MHC class I peptide tetramers

Scandinavian Journal of Immunology

Volumn 67, Issue 1, 2008, Pages 86-94

  Krnic, E Kosor ^a   Gagro, A ^a   Drazenovic, V ^b   Kuzman, I ^c   Jeren, T ^c   Cecuk Jelicic, E ^d   Kerhin Brkljacic, V ^d   Gjenero Margan, I ^e   Kaic, B ^e   Rakusic, S ^c   Sabioncello, A ^a   Markotic, A ^c   Rabatic, S ^a   Mlinaric Galinovic, G ^b   Dekaris, D ^a  

^a INSTITUTE OF IMMUNOLOGY   (Croatia)

^b Croatian Institute of Public Health   (Croatia)

^c Dr Fran Mihaljevi University Hospital for Infectious Diseases   (Croatia)

^d UNIVERSITY OF ZAGREB   (Croatia)

^e CROATIAN NATIONAL INSTITUTE OF PUBLIC HEALTH   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HEMAGGLUTININ; INFLUENZA VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CD8+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INFLUENZA; INFLUENZA VACCINATION; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; CD8-POSITIVE T-LYMPHOCYTES; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HLA-A ANTIGENS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; LYMPHOCYTE COUNT; MIDDLE AGED; NEURAMINIDASE; PEPTIDES; VACCINES, SUBUNIT;

EID: 36749099499     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2007.02042.x     Document Type: Article

References (34)

1. Lamb RA, Krug RM. Ortomyxoviridae: the viruses and their replication. In:Knipe DM, Howley PM, eds. Fields Virology, 4th edn, Vol. 1. Philadelphia, PA:Lippincott Wiliams & Wilkins, 2001:1553 79.
2. Gotch F, McMichael A, Smith G, Moss B. Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes. J Exp Med 1987 165:408 16.
3. Kuwano K, Scott M, Young MJ, Ennis FA. HA2 subunit of influenza A H1 and H2 subtype viruses induces a protective cross-reactive cytotoxic T lymphocyte response. J Immunol 1988 140:1264 8.
4. Ennis FA, Rook AH, Qi YH et al. HLA restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines. Lancet 1981 2:887 91.
5. Altman JD, Moss PA, Goulder PJ et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996 280:1821.
6. Drazenovic V, Ilic A, Sim R, Bozikov J, Mlinaric-Galinovic G. Immune response to influenza vaccine (A/New Caledonia/20/99 (H1N1)-like, A/Moscow/10/99 (H3N2)-like, and B/Bejing/184/93+B/Yamanashi/166/98-like) in elderly. Period Biol 2003 105:147 51.
7. Boon AC, de Mutsert G, Graus YM et al. The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype. J Virol 2002 76:582 90.
8. Gianfrani C, Oseroff C, Sidney J, Chesnut RW, Sette A. Human memory CTL response specific for influenza A virus is broad and multispecfic. Hum Immunol 2000 61:438 52.
9. Jameson J, Cruz J, Ennis FA. Human cytotoxic T-lymphocyte repertoire to influenza A viruses. J Virol 1998 72:8682 9.
10. Benz C, Utermohlen O, Wulf A et al. Activated virus-specific T cells are early indicators of anti-CMV immune reactions in liver transplant patients. Gastroenterology 2002 122:1201 15.
11. Doisne JM, Urrutia A, Lacabaratz-Porret C et al. CD8+ T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection. J Immunol 2004 173:2410 8.
12. Bot A, Bot S, Bona CA. Protective role of gamma interferon during the recall response to influenza virus. J Virol 1998 72:6637 45.
13. Grubic Z, Zunec R, Cecuk-Jelicic E, Kerhin-Brkljacic V, Kastelan A. Polymorphism of HLA-A, -B, -DRB1, -DQA1 and -DQB1 haplotypes in a Croatian population. Eur J Immunogenet 2000 27:47 51.
14. Cecuk-Jelicic E, Grubic Z, Zunec R, Labar B, Kerhin-Brkljacic V, Kastelan A. Implication of molecular analysis of HLA-A*02 subtyping for unrelated bone-marrow donor selection. Bone Marrow Transplant 1998 22:27 30.
15. WHO Recommendations for Influenza Vaccine Composition for Use in the 2001-2002 and 2002-2003 seasons. Available at: http://www.who.int/csr/disease/ influenza/vaccinerecommendations1/en/index6.html and http://www.who.int/csr/ disease/influenza/vaccinerecommendations1/en/index4.html (accessed 3 September 2004).
16. Gotch F, Rothbard J, Howland K, Townsend A, McMichael A. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature 1987 326:881 2.
17. Daisy JA, Lief FS, Friedman HM. Rapid diagnosis of influenza A infection by direct immunofluorescence of nasopharyngeal aspirates in adults. J Clin Microbiol 1979 9:688 92.
18. Potter CW, Oxford JS. Determinants of immunity to influenza infection in man. Br Med Bull 1979 35:69 75.
19. Murasko DM, Bernstein ED, Gardner EM et al. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol 2002 37:427 39.
20. Mbawuike IN, Lange AR, Couch RB. Diminished influenza A virus-specific MHC class I-restricted cytotoxic T lymphocyte activity among elderly persons. Viral Immunol 1993 6:55 64.
21. van Lier RA, ten Berge IJ, Gamadia LE. Human CD8(+) T-cell differentiation in response to viruses. Nat Rev Immunol 2003 3:931 9.
22. Nagorsen D, Monsurro V, Wang E, Marincola FM. Characterization of CD8(-) HLA class I/epitope tetrameric complexes binding T cells. J Immunother 2002 25:379 84.
23. He XS, Mahmood K, Maecker HT et al. Analysis of the frequencies and of the memory T cell phenotypes of human CD8+ T cells specific for influenza A viruses. J Infect Dis 2003 187:1075 84.
24. Cox RJ, Brokstad KA, Zuckerman MA, Wood JM, Haaheim LR, Oxford JS. An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine 1994 12:993 9.
25. Brokstad KA, Cox RJ, Major D, Wood JM, Haaheim LR. Cross-reaction but no avidity change of the serum antibody response after influenza vaccination. Vaccine 1995 13:522 8.
26. Powers DC, Smith GE, Anderson EL et al. Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults. J Infect Dis 1995 171:1595 9.
27. Danke NA, Kwok WW. HLA class II-restricted CD4+ T cell responses directed against influenza viral antigens postinfluenza vaccination. J Immunol 2003 171:3163 9.
28. Kohler B, Puzone R, Seiden PE, Celada F. A systematic approach to vaccine complexity using an automation model of the cellular and humoral immune system. I. Viral characteristics and polarized responses. Vaccine 2000 19:862 76.
29. Deng Y, Jing Y, Campbell AE, Gravenstein S. Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J Immunol 2004 172:3437 46.
30. Betts MR, Casazza JP, Patterson BA et al. Putative immunodominant human immunodeficiency virus-specific CD8(+) T-cell responses cannot be predicted by major histocompatibility complex class I haplotype. J Virol 2000 74:9144 51.
31. Dunn HS, Haney DJ, Ghanekar SA, Stepick-Biek P, Lewis DB, Maecker HT. Dynamics of CD4 and CD8 T cell responses to cytomegalovirus in healthy human donors. J Infect Dis 2002 186:15 22.
32. Valitutti S, Muller S, Dessing M, Lanzavecchia A. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J Exp Med 1996 183:1917 21.
33. Webster RG, Askonas BA. Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. Eur J Immunol 1980 10:396 401.
34. Hobeika AC, Morse MA, Osada T et al. Enumerating antigen-specific T-cell responses in peripheral blood: a comparison of peptide MHC Tetramer, ELISpot, and intracellular cytokine analysis. J Immunother 2005 28:63 72.